Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study.
Miao ShaoMiao MiaoXia ZhangXiaoying ZhangYuan AnHuifang GuoLingyan LeiQing ZhaoYanjie DingJin LinRui WuFeng YuYucui LiHuali MiaoLiyun ZhangYan DuRuiying JiaoLixia PangLi LongXueming YaoXiaofei ShiFei WangLuping CuiLei ZhangShengyun LiuFuai LuKangkai LuoSimeng ZhaoYongfu WangXiao WuQingwen WangHongjiang LiuShulin SongXiaoyuan ZhouXiaoping ZhangShumei ShiHong ZhuYao ChenHonglian YuJie WuRuiyun YuWenqiang FanShuang LiuJian XuZhibin ChenLianjie ShiJing HeXuewu ZhangZhan-Guo LiRu LiPublished in: Lupus science & medicine (2022)
SILD IV-CYC showed a lower frequency of infection events than high-dose IV-CYC in patients with SLE.